Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents
Tóm tắt
Despite the significant impact of pharmaceutical innovations on healthcare, our understanding is still limited because previous studies explored only a few cases and largely came from a linear perspective. This study presents a detailed case of the Chinese and U.S. pharmaceutical patents and investigated advancements that the global pharmaceutical industry is experiencing. A network analysis approach was used to identify certain aspects regarding the diffusion of pharmaceutical innovations, including innovation attributes, adopter characteristics, and clustering. Based on a patent database, network analysis and visualization, this study captured the structure of patent networks for the global pharmaceutical landscape in a large set of patents. A large volume of patent data, 15,422 patent filings citing Chinese pharmaceutical patents, 28,075 citing U.S. patents, and 6064 citing both Chinese and U.S. patents during 2014–2015, were retrieved from the world patent database, Derwent Innovation Index. The networks reveal many interesting features of technological innovation, convergence trends and diffusion patterns. Convergence innovations were identified, with the advantage and influence of U.S. patents shown in a variety of areas, and their Chinese counterparts were concentrated in traditional Chinese medicine. Early adopters of Chinese patents were mainly universities within the national sector, while early adopters of U.S. patents were academic institutions and large international pharmaceutical corporations of balanced quantity, contributing a higher degree of technology convergence. Technology convergence in the cancer-treatment sector is expected to have a high future development potential. Chinese and U.S. pharmaceutical innovations contributed differently to the growth and development of the global pharmaceutical industry. The findings of this study can provide rich knowledge about the influence, diffusion and convergence trends of Chinese and U.S. pharmaceutical innovations. In the pharmaceutical industry, the findings may provide implications for researchers, policy makers, health professionals, and the general public to help improve the overall health of society.
Tài liệu tham khảo
Deng MM. China patent law and implications for international pharmaceutical companies. Expert Rev Clin Phar. 2010;3:713–6.
Malerba F. The evolution of the pharmaceutical industry. Bus Hist. 2015;57:664–87.
Empowering People A-SN. Organizations through information. J Health Commun. 2012;17:1–4.
Yancey A, Stewart CN Jr. Patent reform in the US: what's at stake for pharmaceutical innovation? Expert Opin Ther Pat. 2010;20:603–8.
Chataway J, Tait J, Wield D. Frameworks for pharmaceutical innovation in developing countries—the case of Indian pharma. Technol Anal Strateg. 2007;19:697–708.
Malik NN. Key issues in the pharmaceutical industry: consequences on R&D. Expert Opin Drug Dis. 2009;4:15–9.
Slinn J. Patents and the UK pharmaceutical industry between 1945 and the 1970s. Hist Technol. 2008;24:191–205.
Magazzini L, Pammolli F, Riccaboni M, Rossi MA. Patent disclosure and R&D competition in pharmaceuticals. Econ Innovation New Tech. 2009;18:467–86.
Bradfield R, El-Sayed H. Four scenarios for the future of the pharmaceutical industry. Technol Anal Strateg. 2009;21:195–212.
Muzaka V. Prizes for pharmaceuticals? Mitigating the social ineffectiveness of the current pharmaceutical patent arrangement. Third World Q. 2013;34:151–69.
Gilmartin RV. One point of view: winning in pharmaceutical research. Res Technol Manage. 1998;4:9–12.
Hu Y, Scherngell T, Qiu L, Wang Y. R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective. Technol Anal Strateg. 2015;27:532–49.
Steele PR. Patenting of pharmaceuticals by academic institutions. Expert Opin Ther Pat. 1997;7:1251–6.
Hu T, Myers M. A comparison between China and U.S. drug Laws. Clin Res P Drug Regul Aff. 1988;6:257–92.
Yeung G. The implications of WTO accession on the pharmaceutical industry in China. J Contemp China. 2002;11:473–93.
Ding Z, Zheng X, Wu X. Strategies for expanding the international influences of Academic Journals. Serials Rev. 2012;38:80–5.
Motohashi K. Catching up or lagging behind? Assessment of technological capacity of China by patent database. China Econ J. 2009;2:1–24.
Xie H, Zhang H, Zhang S, He S. Analysis of antibiotic patents issued in China from 1992 to 2011. Expert Opin Ther Pat. 2012;22:1205–32.
Xie H, Zhang H, Cao K, He P, Dai H, He S. Analysis of anti-asthmatic drug patents published in China between 2004 and 2013. Expert Opin Ther Pat. 2016;26:363–76.
Sucher NJ. The application of Chinese medicine to novel drug discovery. Expert Opin Drug Dis. 2013;8:21–34.
Doyal L. Health, underdevelopment and traditional medicine. Holistic Med. 1987;2:27–40.
Xu W, Xing FJ, Dong K, You C, Yan Y, Zhang L, Zhao G, Chen Y, Wang K. Application of traditional Chinese medicine preparation in targeting drug delivery system. Drug Deliv. 2015;22:258–65.
Cui L, Su X. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti-Infect Ther. 2009;7:999–1013.
Gilman NV. Analysis for science librarians of the 2015 Nobel prize in physiology or medicine: the life and work of William C. Campbell, Satoshi Ōmura, and Youyou Tu. Sci Tech Libr. 2016;35:35–58.
Hsu E. Chinese propriety medicines: an “alternative modernity?” the case of the anti-malarial substance artemisinin in East Africa. Med Anthropol. 2009;28:111–40.
Njuguna NM, Ongarora DSB, Chibale K. Artemisinin derivatives: a patent review (2006–present). Expert Opin Ther Pat. 2012;22:1179–203.
The 2015 Nobel prize in physiology or medicine – press release. In: Nobelprize.org. 2016. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.html. Accessed 12 Dec 2016.
Youyou Tu – Nobel Lecture: Discovery of Artemisinin - A Gift from Traditional Chinese Medicine to the World. In: Nobelprize.org. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/tu-lecture.html.2016. Accessed 12 Dec 2016.
Lichtenberg FR. Pharmaceutical innovation and the burden of disease in developing and developed countries. J Med Philos. 2005;30:663–90.
Rogers EM. Diffusion of innovations. New York: Free Press; 2003.
Rogers EM. A prospective and retrospective look at the diffusion model. J Health Commun. 2004;9:13–9.
Moseley SF. Everett Rogers’ diffusion of innovations theory: its utility and value in public health. J Health Commun. 2004;9:149–51.
Dearing JW. Improving the state of health programming by using diffusion theory. J Health Commun. 2004;9:21–36.
Haider M, Kreps GL. Forty years of diffusion of innovations: utility and value in public health. J Health Commun. 2004;9:3–11.
Hornik R. Some reflections on diffusion theory and the role of Everett Rogers. J Health Commun. 2004;9:143–8.
Diffusion Methodology MG. Time to Innovate? J Health Commun. 2004;9:59–69.
Ratzan SC. Health information: diffusing information to knowledge and action. J Health Commun. 2011;16:923–4.
Hafner KA. The pattern of international patenting and technology diffusion. Appl Econ. 2008;40:2819–37.
Lee C, Kim J, Noh M, Woo H, Gang K. Patterns of technology life cycles: stochastic analysis based on patent citations. Technol Anal Strateg. 2016; https://doi.org/10.1080/09537325.2016.1194974.
Wang JH, Tsai C. National Model of technological catching up and innovation: comparing patents of Taiwan and South Korea. J Dev Stud. 2010;46:1404–23.
Fink C, Khan M, Zhou H. Exploring the worldwide patent surge. Econ Innovation New Tech. 2016;25:114–42.
Choi JY, Jeong S, Kim K. A study on diffusion pattern of technology convergence: patent analysis for Korea. Sustainability. 2015;7:11546–69.
Macklis RM, Sharma N. Convergence technology in cancer medicine. Expert Rev Med Devices. 2011;8:263–73.
Lee K. Toward a new paradigm of technological innovation: convergence innovation. Expert Rev Med Devices. 2015;23:1–8.
Jang Y. Technological convergence through industrial research collaboration: a comparative analysis between the U.S. and Korea. Asian J Technol Inno. 2009;17:101–20.
Chen Y, Chang K. Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry. Technol Anal Strateg. 2010;22:153–69.
Radosevic S. Technological 'Catching-up' potential of central and Eastern Europe: an analysis based on US foreign patenting data. Technol Anal Strateg. 1999;11:95–111.
Vadrot ABM. “Rather a manager and networker than a researcher”: converging technologies in the clinic. Innov. 2013;26:376–97.
You Y, Kim B, Jeong E. An exploratory study on the development path of converging technologies using patent analysis: the case of nano biosensors. Asian J Technol Inno. 2014;22:100–13.
Tegart G. Converging technologies and their implications for technology transfer: the cases of European networks (N EuroNet) and NBIC (nano-bio-info-cogno) technologies as drivers of change. Innov. 2005;7:468–76.
Siedlok F, Smart P, Gupta A. Convergence and reorientation via open innovation: the emergence of nutraceuticals. Technol Anal Strateg. 2010;22:571–92.
Cameron G, Proudman J, Redding S. Technological convergence, R&D, trade and productivity growth. Eur Econ Rev. 2005;49:775–807.
Kumar S, Russell RR. Technological change, technological catch-up, and capital deepening: relative contributions to growth and convergence during 90’s. Am Econ Rev. 2002;92:527–48.
Zhao D, Strotmann A. The Knowledge Base and research front of information science 2006-2010: an author Cocitation and bibliographic coupling analysis. J Assoc Inf Sci Technol. 2014;65:995–1006.
Jeong S, Kim JC, Choi JY. Technology convergence: what developmental stage are we in? Scientometrics. 2015;104:841–71.
Kim C, Kim M. Identifying core environmental technologies through patent analysis. Innov. 2015;17:139–58.
Luan CJ, Liu ZY, Wang XW. Divergence and convergence: technology-relatedness evolution in solar energy industry. Scientometrics. 2013;97:461–75.
Yu F, Wu Y. Patent citations and knowledge spillovers: an analysis of Chinese patents registered in the USA. Asian J Technol Inno. 2014;22:86–99.
Preschitschek N, Niemann H, Moehrle MG. Semantic analyses vs. IPC co-classification analyses of patents: which one better serves to anticipate converging industries? In: Proceedings of Technology Management for Emerging Technologies (PICMET) 2012. 2012. http://ieeexplore.ieee.org/document/6304076/authors. Accessed 15 Jan 2016.
Kim E, Cho Y, Kim W. Dynamic patterns of technological convergence in printed electronics technologies: patent citation network. Scientometrics. 2014;98:975–98.
Yang S, Han R, Wolfram D, Zhao Y. Visualizing the intellectual structure of information science (2006-2015): introducing author keyword coupling analysis. J Inf Secur. 2016;10:132–50.
Huang J, Tang J, Qu Y, Zhang L, Zhou Y, Bao S, Mu D. Mapping the knowledge structure of neonatal hypoxic-ischemic encephalopathy over the past decade: a co-word analysis based on keywords. J Child Neurol. 2016;31:797–803.
Mogee ME, Kolar RG. Patent citation analysis of Allergan pharmaceutical patents. Expert Opin Ther Pat. 1998;8:1323–46.
Naghizadeh R, Elahi S, Manteghi M, Ghazinoory S, Ranga M. Through the magnifying glass: an analysis of regional innovation models based on co-word and meta-synthesis methods. Qual Quant. 2015;49:2481–505.
Thijs B, Zhang L, Glanzel W. Bibliographic coupling and hierarchical clustering for the validation and improvement of subject-classification schemes. Scientometrics. 2015;105:1453–67.
Chen C. CiteSpace: 2003–2013. 2013. http://cluster.cis.drexel.edu/~cchen/citespace/. Accessed 15 Jan 2016.
Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57:359–77.
Persson O. Bibexcel. 2013. http://www.soc.umu.se/english/research/bibexcel/. Accessed 15 Jan 2016.
Chase R, Borgatti S. Analytic technologies-Ucinet. 2013. http://www.analytictech.com/downloaduc6.htm. Accessed 15 Jan 2016.
Chen C. Predictive effects of structural variation on citation counts. J Am Soc Inf Sci Technol. 2012;63:431–49.
Chen C, Leydesdorff L. Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis. J Assoc Inf Sci Technol. 2014;65:334–51.
Ma J, Porter AL. Analyzing patent topical information to identify technology pathways and potential opportunities. Scientometrics. 2015;102:811–27.
Kim M, Zhu Y, Chen C. How are they different? A quantitative domain comparison of information visualization and data visualization (2000-2014). Scientometrics. 2016;107:123–65.
Johnson JD. UCINET – a software tool for network analysis. Commun Educ. 1987;36:92–4.
Peres M, Xu H, Wu G. Community evolution in international migration Top1 networks. PLoS One. 2016; https://doi.org/10.1371/journal.pone.0148615.
Niosi J. Rethinking science, technology and innovation (STI) institutions in developing countries. Innov. 2010;12:250–68.
Lofstedt RE. The impact of the Cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implications. J Health Commun. 2007;12:471–91.
Ren S, Su P. Open innovation and intellectual property strategy: the catch-up processes of two Chinese pharmaceutical firms. Technol Anal Strateg. 2015;27:1159–75.